Mount Sinai Venture Named to Fast Company’s Annual List of the World’s Most...
Kantaro Biosciences among top-ranked in the Joint Venture category Mount Sinai Health System announced today that Kantaro Biosciences, LLC, a joint venture with RenalytixAI, has been named to Fast...
View ArticlePitch Challenge 2021 Contestant George Foulard, MD, Discusses Platform for...
George Foulard, MD, a Diagnostic Radiology Resident at The Mount Sinai Hospital, is presenting Bedboard at the Mount Sinai Pitch Challenge on May 5. Bedboard, an information technology platform that...
View ArticleTrellus Health Announces Experienced Leaders to Drive Next Phase of Growth
Industry veterans from Teladoc Health, Talkspace, Harwood Capital and Polar Capital join executive team and board of directors Trellus Health, a leading resilience-driven connected health solution for...
View ArticleKantaro’s COVID-SeroKlir Antibody Test Named as a Finalist for Fast Company’s...
Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENX / NASDAQ: RNLX), announced today that COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG...
View ArticleMeet Charles Mobbs, PhD, of Team Gilga-Med: the Winner of the Mount Sinai...
Charles Mobbs, PhD, Professor in the Departments of Geriatrics and Palliative Care, Neuroscience, and Medicine at the Icahn School of Medicine at Mount Sinai, won the Mount Sinai Pitch Challenge on May...
View ArticleUK Vivan Therapeutics Secures Expanded Drug Discovery & Development Platform...
My Personal Therapeutics Ltd. (trading as Vivan Therapeutics), a UK-based company, announces an expansion of its licensed technology rights from Mount Sinai Health System. Scientists at the Icahn...
View ArticleKantaro’s Semi-Quantitative Antibody Test Kit Receives Health Canada...
-COVID-SeroKlir detects both the presence and precise level of neutralizing IgG antibodies with 98.8% sensitivity and 99.6% specificity -Available immediately and can be used in Canadian laboratories...
View ArticleMount Sinai Health System Launches Elementa Labs, A Virtual Incubator Program
Elementa Labs will connect health care startup companies with Mount Sinai’s vast network of research and clinical experts to advance groundbreaking health care innovations. Mount Sinai Innovation...
View ArticleBreaking Boundaries in Science and in Life: How Yasmin Hurd, PhD, is Paving...
Neuroscientist Yasmin Hurd, PhD, has a natural way of connecting with people. Whether through her many research publications, a TED Talk, or during a virtual meeting with two team members of Mount...
View ArticleFirst Demonstration Contract with Mount Sinai Employee Health Plan for...
Trellus Health plc (AIM: TRLS), which is commercialising a scientifically validated, resilience-based, connected health solution for chronic condition management, is pleased to announce that it has...
View ArticleMount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled...
Targeted testing run rate of 300 diabetic kidney disease patients per week in calendar Q4 2021 Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up...
View ArticleNew Partnership Agreement & Licensed Clinical Team Established with Three...
Trellus Health plc (AIM: TRLS), which is commercialising a scientifically validated, resilience-based, connected health solution for chronic condition management, announces it has established a...
View ArticleBridgeBio Pharma Announces Collaborations with Columbia University and Mount...
BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced two new academic collaborations with Columbia University and...
View ArticleSema4 and Mount Sinai use Machine Learning to Improve Postpartum Hemorrhage...
Sema4, an AI-driven genomic and clinical data intelligence platform company, recently published two studies demonstrating the utility of machine learning to predict clinical outcomes for postpartum...
View ArticleMount Sinai Spin-Off Linus Biotechnology Inc. to Revolutionize Precision...
Linus Biotechnology Inc. and Mount Sinai Innovation Partners (MSIP) today announced an exclusive worldwide license and collaboration agreement in progress with the Icahn School of Medicine at Mount...
View ArticleLinus Biotechnology Inc. Receives FDA Breakthrough Device Designation for...
Linus Biotechnology Inc., a leader in precision exposome sequencing, today announced that the U.S. Food and Drug Administration Center for Devices and Radiological Health has granted the Company’s...
View ArticleMSIP Honors SARS-CoV-2 and Drug Discovery Research Teams at Innovation Awards...
At the annual Innovation Awards Ceremony on November 8, Mount Sinai Innovation Partners (MSIP) presented the Inventor of the Year, Transaction of the Year, and Mount Sinai Pitch Challenge awards to...
View ArticlePreciseDx Raises $10.75 Million Series A Preferred from Healthcare Industry...
Services Improve the Information Available to Oncologists and Pathologists in Determining Patient Risk Profiles and Treatment Diagnostic Industry Veteran Wayne Brinster Joins as CEO PreciseDx, the only...
View Article
